Behind every pulmonary hypertension patient is a caregiver navigating complex therapies, long-distance travel, and financial strain — often without recognition or support. This #RareDiseaseDay, read Liquidia's Seth Hall’s piece on why caregivers deserve to be seen as partners in care, not just background support. liquidia.com/static-files/3f…

Liquidia announced today the company will present clinical data across its portfolio at the Pulmonary Vascular Research Institute (PVRI) 2026 Annual Congress to be held 1/28 – 2/1 in Dublin, Ireland. See today’s press release: bit.ly/4rexn23.

Liquidia will present at the J.P. Morgan Healthcare Conf. on Weds, 1/14/26 beginning at approx. 5:15 p.m. PT / 8:15 p.m. ET. Access to the webcast will be available on the “Investors” page of Liquidia’s site at bit.ly/49nT08O & will be archived for at least 30 days.

Liquidia is currently hiring talent to advance our multi-disciplinary R&D programs. We encourage applications from those who excel in their field of expertise & enjoy a fast-paced, challenging work environment. Learn more at: bit.ly/48wGpQi

Liquidia is seeking a Senior Manager/Associate Director to join our Patient Marketing team and support our ongoing launch of YUTREPIA™. To learn more about this position and others, please visit Liquidia’s Career page at bit.ly/3XR8cG4.

Last week, we broke ground on our new manufacturing facility at Pathway Triangle in Morrisville, NC. This expansion will boost capacity, add 60 jobs, and strengthen RTP’s life sciences hub to better serve patients with rare cardiopulmonary & vascular diseases.

Liquidia proudly joined the 2nd Annual PHenomenal Hope Run/Walk! Thank you @teamphhope for creating a space where patients, caregivers, healthcare providers and advocates can connect and make a difference. To get involved, visit bit.ly/4r5jVOX. #PHAwarenessMonth

Today we announced our participation in fireside chats at the following two investor conferences taking place in November -- 2025 UBS Global Healthcare Conference and Jefferies London Healthcare Conference. To learn more, see today’s press release at bit.ly/3JzLb7c.

Liquidia Corporation (NASDAQ: LQDA) announced today its 3Q’25 financial results. The company provided an overview of its financial results & a corp update via a live webcast today at 8:30 a.m. ET. To read today’s release: bit.ly/4oPNi5M.

During Pulmonary Hypertension Month, we’re proud to stand with the PH community by raising awareness and much-needed funds for research, support services and educational resources for patients in need. #PHAwarenessMonth #TeamLiquidia #PHCommunity #PulmonaryHypertension

Liquidia is seeking a hands-on, experienced Manufacturing Technician to support both production and R&D operations. To learn more this position and others, please visit Liquidia’s Career page at liquidia.com/careers.

Liquidia Corporation (NASDAQ: LQDA) announced today it will report its third quarter 2025 financial results on November 3, 2025, via a live webcast at 8:30 a.m. ET. See today’s press release for more info: bit.ly/47mEQ6U.

Today Liquidia announced it will host an R&D Day on Tuesday, 10/28/25, in NYC which will be webcast from 2:00 p.m. to 4:30 p.m. EST. See today’s press release for more information: bit.ly/3VTLpbN

During National Healthy Lung Month, Liquidia remains committed to delivering life-saving therapies to patients fighting rare cardiopulmonary diseases like #PAH and #PHILD. Learn more about our work at bit.ly/4nSpSvY.

Today Liquidia announced it will present clinical data from its ASCENT trial at the CHEST 2025 annual meeting on October 21, 2025, in Chicago. See today’s press release for more information: bit.ly/4mFT7Bk.

Liquidia proudly sponsored & participated in this week’s @NCLifeSci Annual Meeting where our SVP of Manufacturing Operations, Michael Hunter, spoke about the benefits of doing business in North Carolina's increasingly expanding biotech hub - Research Triangle Park.

Today Liquidia announced it will present four posters at the Pulmonary Hypertension Professional Association (PHPN) Symposium taking place September 18-20, 2025, in Seattle. See today’s press release for more information: bit.ly/42sLarN.

Today we announced our upcoming participation in the 2025 Wells Fargo Healthcare Conf. where our CFO/COO, Michael Kaseta, & CBO, Jason Adair, will be providing a business update on Weds. 9/3 at 3:45 p.m. ET. To register, visit bit.ly/3DSsWXQ.

Liquidia Corporation (NASDAQ: LQDA) announced today its 2Q’25 financial results. The company will provide an overview of its financial results & a corp update via a live webcast today at 8:30 a.m. ET. To register: bit.ly/41BhLLz. To read today’s release: bit.ly/4mdzMIp.

Liquidia Corporation (NASDAQ: LQDA) announced today it will report its second quarter 2025 financial results on August 12, 2025, via a live webcast at 8:30 a.m. ET. See today’s press release for more info: bit.ly/4lgSJZ7.